PATENT CLAIM ANALYSIS

Application Number: 15926577
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "423000"]

Abstract:
This disclosure describes the use of cationic steroidal antimicrobial (CSA) compounds to prevent microbial fouling of medical implants, including microbial fouling caused by bacterial and/or fungal biofilms. The CSAs are incorporated into the medical implants to provide effective antimicrobial properties. A medical implant includes a component formed from a polymeric material. A plurality of CSA molecules are mixed with the polymeric material so that the CSA molecules are incorporated into the structure of the medical implant as formed. A medical implant can additionally or alternatively include a lubricious coating containing CSA molecules.

Claim (Index 5):
The method of  claim 4 , wherein the coating is a hydrogel.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.63934
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15454135', '15585632', '14750928', '13554957', '14848819']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7528583318418413
- 35 USC 102 Novelty (BERT): 0.5210259213768135
- Combined Prediction Score: 0.7296750907953384
- Mean Citation Score: 277.560558
- Max Citation Score: 313.33875
- Similarity Product: 211.86506787031888

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test